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Paragangliomas of the urinary bladder are very rare. To date, there are no reliable methods
for predicting their clinical behavior, so long-term follow-up is required. We describe a
paraganglioma of the urinary bladder in a 32-year-old male who presented with painless
gross hematuria. Abdominal ultrasonography revealed a protruding mass with hematoma
over the right lateral wall of the urinary bladder. The tumor was not completely resected
by transurethral resection of bladder tumor (TURBT) due to intermingling with the bladder
wall. Follow-up I131-metaiodobenzylguanidine was performed 3 weeks after surgery and
suspected incomplete resection lesions were noted. Histologic examination of the tumor
indicated paraganglioma of the urinary bladder. We also provide a brief review of the
literature for comparison.
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Neoplasms arising from chromaffin cells of the sym-
pathetic nervous system are called pheochromocytomas.
Approximately 70% of pheochromocytomas arise in
the adrenal medulla. Extra-adrenal tumors identified
as pheochromocytomas are referred to as extra-adrenal
paragangliomas. These arise predominantly in the
retroperitoneum, from the upper abdomen to the pelvic
floor. The urinary bladder can also be a primary site of
extra-adrenal paragangliomas; 9.8% of extra-adrenal
paragangliomas arise from the urinary bladder [1],
although paragangliomas account for only 0.06% of all
tumors of the urinary bladder [2]. Herein, we describe a
32-year-old male with primary paraganglioma of the
urinary bladder and review the literature on the subject.
CASE PRESENTATION
A 32-year-old male heavy smoker had excellent health
until 3 days before admission, when painless gross
hematuria with blood clots developed. He visited our
hospital for urologic investigation. According to his
statement, he had also suffered from voiding with
palpitation and headache for 2 years.
Findings on physical examination were not
remarkable. Resting blood pressure on admission was
120/70 mmHg and his urine analysis revealed a red
blood cell count (RBC) of more than 100/high-power
field (HPF), a white blood cell count (WBC) of 10–25/
HPF, and protein of more than 300 mg/dl; all other
laboratory examinations were unremarkable.
Abdominal ultrasound showed a large protruding
tumor over the right lateral wall with hematoma
extension to the base of the urinary bladder (Figure 1).
The maximal diameter of the tumor was 3.0 cm. No
lesion was found on imaging studies, including
roentgenography of the kidneys, ureter, and bladder
(KUB) and chest.
Cystoscopy showed an exophytic tumor with
normal covering mucosa from the right lateral wall
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near the neck of the urinary bladder. Transurethral
resection of bladder tumor (TURBT) was performed
for suspected tumor of the urinary bladder. During
surgery, the surgeon found that the tumor was
hypervascular and had involved the muscular wall of
the bladder, so the tumor was resected incompletely.
Because the mucosa of the bladder neck was abnormal,
bilateral prostate biopsy was also performed.
On pathologic examination of the specimen, more
than 10 pinkish and elastic tumor fragments were
obtained. Microscopic histologic examination showed
ovoid to polygonal and slightly spindle-shaped cells
with abundant amphophilic to eosinophilic cytoplasm,
containing many foamy granules. The nuclei were
round and vesicular with occasional mitotic activity.
The tumor cells were arranged in a characteristic
Zellballen pattern with short, irregular anastomosing
sheets around a delicate vasculature (Figure 2). Neither
nuclear anaplasia nor vascular invasion were found.
Immunohistochemical study demonstrated the
presence of neuron-specific enolase, chromogranin,
synaptophysin, and S-100 protein but the absence of
cytokeratin, vimentin, leukocyte common antigen, and
epithelial membrane antigen. Histologic diagnosis was
paraganglioma of the urinary bladder.
Electron microscopic study revealed an admixture
of light and dark cells with dense-core neurosecretory
granules, which were more numerous in dark cells
(Figure 3).
Follow-up I131-metaiodobenzylguanidine (MIBG)
scan was performed 3 weeks after TURBT and revealed
a radioactive focus in the right side of the urinary
bladder throughout the serial 24-, 48-, and 72-hour
images, even post voiding. The results suggested local
residual paraganglioma involving the urinary bladder
with low probability of distant metastasis.
DISCUSSION
Paragangliomas of the urinary bladder are rare, with
only a few case reports published in Taiwan [3,4].
From the first description by Zimmerman et al in 1953
to 1999, more than 160 cases have been reported
Figure 1. Pelvic ultrasonography reveals a tumor mass (arrow)
over the right lateral wall (left), with blood clots (arrow) over the
basal area of the urinary bladder (right).
Figure 2. Tumor cells arranged in characteristic Zellballen
pattern around a delicate vasculature. (Hematoxylin & Eosin,
original magnification x 100.) Tumor cells are ovoid to polygonal
and have a granular cytoplasm (arrow). There is no nuclear
anaplasia. (Insert: Hematoxylin & Eosin, original magnification
x 400.)
Figure 3. Dense-core neurosecretory granules (arrow) are found
within the tumor cells under the electron microscope. (Original
magnification x 12,000.)
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worldwide [5–7]. At diagnosis, patients were between
11 and 84 years old [8]; there were slightly more
females than males [9–11]. The tumors originate from
neuroectodermal tissue within the bladder wall and
common sites are the trigone followed by the dome
and bilateral wall [6,11]. Tumors are relatively small,
ranging from a few millimeters to 10 cm with an
average of 1.9 cm [8].
The characteristic symptom complex is associated
with catecholamine excess, and includes hypertension,
dizziness, headache, tachycardia, and palpitation,
triggered by micturition, bladder distension, or sexual
intercourse. Painless hematuria, frequency, and
dysuria are also common. Biochemical study is based
on 24-hour urine and serum concentrations of
vani l ly lmandel ic  ac id  (VMA),  epinephrine ,
norepinephrine, and metanephrine; specimens must
be drawn during attacks to avoid false negatives.
However, Bravo et al found that 50% of their patients
with pheochromocytoma had urinary VMA within
the normal range [12]. Other diagnostic workups
include abdominal ultrasound, computerized
tomography (CT) scan, and I131-MIBG scan, which is
the most useful tool in the diagnosis of extra-adrenal
tumors arising from the paraganglion system or in
metastatic lesions.
Paragangliomas of the urinary bladder have his-
tologic features similar to adrenal pheochromocytoma.
Tumors are often poorly circumscribed and
intermingled with adjacent muscle bundles of the
bladder wall. The typical Zellballen pattern (cell
clusters) of growth is the most common variant.
Trabecular, ribbon, and sarcomatoid patterns have
also been reported. Like many other endocrine tumors,
bizarre cells are not uncommon. Low-grade transitional
cell carcinoma should be included in the differential
diagnosis. When tumors have a spindle-cell pattern,
differential diagnosis should include Schwann cell
and smooth muscle neoplasm.
About 5–15% of urinary paragangliomas are
diagnosed as malignant [8]. As in pheochromocytoma,
there is no ideal histologic evaluation for the malignant
potential of paraganglioma of the urinary bladder.
Characteristics such as nuclear atypia, mitotic activity,
vascular invasion, and infiltrating growth pattern do
not contribute to malignant potential. As noted by
Neville, the only absolute criterion for diagnosing
malignancy is the presence of tumor in sites where
paraganglionic tissue is not normally found [13].
However, it is difficult to tell true metastasis from
multifocal development of the tumor in some cases.
Even in patients who have developed metastatic
lesions, there is still no histologic feature distinguishing
between malignant and benign tumors.
Kliewer et al suggested that the presence of
sustentacular cells is associated with benign behavior,
and that these cells seem to be absent in aggressively
metastatic paragangliomas [14,15]. However, Grignon
et al indicated that numerous sustentacular cells were
present in a case that showed malignant behavior [2].
The same result was noted by Korat et al in one of three
malignant extra-adrenal paragangliomas [16]. Anton
et al and Pugh [17,18] have suggested that the amount
of dopa and dopamine secretion is different in benign
and malignant paragangliomas [17]. However, a case
of malignant urinary bladder paraganglioma with no
increased dopa secretion has been reported [19]. In
1986, a flow cytometry study by Hosaka et al showed
that polyploidy or nuclear content are significant
predictors of  malignant behavior in adrenal
pheochromocytomas [20]. Grignon et al studied three
urinary bladder paragangliomas and found an
aneuploid DNA pattern in two cases and a diploid
pattern in the other case [2]. One case with aneuploid
DNA was alive and well 7 years after diagnosis and the
other died of an unrelated cause. The patient with
diploid DNA had local recurrence five times after first
surgery. According to this study, DNA ploidy seems
not to be a useful predictor of malignancy in urinary
bladder paraganglioma [1]. To sum up, there are
currently no reliable methods predicting the clinical
behavior of urinary bladder paragangliomas, so long-
term follow-up is necessary, including measuring blood
pressure and catecholamine concentrations and I131-
MIBG scanning.
Because of the small number of cases and the smaller
number of cases followed up, the prognosis of urinary
bladder paraganglioma is not well established. One
study revealed a 5-year survival rate of 44% in
malignant adrenal pheochromocytomas and that extra-
adrenal paraganglioma had worse prognosis than
adrenal pheochromocytoma [21]. However, another
report showed that urinary bladder paraganglioma
had the same prognosis as adrenal pheochromocytoma
[22].
Blood pressure control, preoperative hydration,
and a skilled anesthesia team are essential to avoid
blood pressure dropping off suddenly during surgery.
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The surgical  t reatment  for  ur inary bladder
paraganglioma depends on the location and extent of
the tumor. TURBT can remove a tumor successfully in
some patients. When the location and size do not
allow complete transurethral resection, partial
cystectomy or total cystectomy with or without pelvic
lymph node dissection is considered. In our case, we
advised the patient to undergo partial cystectomy or
total cystectomy for complete removal of the residual
tumor. Due to neither hematuria nor voiding with
palpitation and headache after TURBT, he refused
further surgical intervention even though he was
informed of the possibility of regrowth and the
malignant potential of the residual tumor.
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